Skip to main content

Scholar Rock Holding Corp

SRRK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001727196

In the last 90 days, Scholar Rock Holding Corp insiders filed 0 open-market purchases and 5 sales; 306 institutions reported holding it in 13F filings for Q2 2026, worth $7.63B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Scholar Rock Holding Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
5 filings
5 insiders, $923.1K in total
Insiders trading
5
Net value
−$923.1K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Scholar Rock Holding Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Scholar Rock Holding Corp
NameTitleLast reported holdingLast filingFilings, past year
Woods KeithChief Operating Officer572,021Sep 25, 20264
Hallal DavidChief Executive Officer1,602,382Sep 23, 20265
Flier Jeffrey S.Director27,856Jul 6, 20262
Gilman MichaelDirector59,511Jul 6, 20262
Burow KristinaDirector114,657Jul 6, 20263
Reed JoshuaDirector19,518Jul 6, 20262
Peng KatieDirector34,301Jul 6, 20263
Akkaraju SrinivasDirector27,971Jun 8, 20263
Brudnick RichardDirector21,896Jun 8, 20261
Sinha VikasChief Financial Officer619,856Apr 20, 20263
Vaishnaw AkshayPresident of R&D630,542Apr 20, 20263
Qatanani MoCHIEF SCIENTIFIC OFFICER98,445Feb 25, 20267
Marantz Jing L.CHIEF MEDICAL OFFICER126,012Feb 19, 20263
Ho JunlinGENERAL COUNSEL241,545Feb 19, 20263
Parlavecchio CarynCHRO169,087Feb 19, 20263
Debbane Raymond10% Owner10,825,013Feb 6, 20261
Siren, L.L.C.10% Owner10,825,013Feb 6, 20261
Invus Global Management, LLC10% Owner10,825,013Feb 6, 20261
Sacco TraceyChief Commercial Officer71,750Apr 29, 20250
Moore ErinInterim PFO and PAO82,609Mar 25, 20250
Myles Edward HCOO & CFO111,345Mar 12, 20250
Backstrom Jay T.CHIEF EXECUTIVE OFFICER425,561Mar 12, 20250
Invus Public Equities Advisors, LLC10% Owner9,250,005Dec 12, 20240
Invus Public Equities, L.P.10% Owner9,250,005Dec 12, 20240
Nashat AmirDirector38,639May 13, 20240
Samsara BioCapital, L.P.10% Owner6,788,609IndirectOct 18, 20230
Samsara BioCapital GP, LLC10% Owner6,788,609IndirectOct 18, 20230
Artal Group S.A.10% Owner11,259,438Oct 16, 20230
Artal International S.C.A.10% Owner11,259,438Oct 16, 20230
Westend S.A.10% Owner11,259,438Oct 16, 20230
Stichting Administratiekantoor Westend10% Owner11,259,438Oct 16, 20230
Artal International Management S.A.10% Owner11,259,438Oct 16, 20230
Wittouck Amaury10% Owner11,259,438Oct 16, 20230
Mahanthappa Nagesh K.Interim CEO and President480,491Jun 21, 20220
Carven Gregory JohnChief Scientific Officer128,208Jun 21, 20220
Chyung Yung H.Chief Medical Officer258,496Feb 15, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 28, 2021 (view filing)Jul 262 daysFlier Jeffrey S.DirectorSSale−6.00K$31.66−$189.9K−17.5%28.3K after2 lots
Sep 21, 2021 (view filing)Sep 201 dayFlier Jeffrey S.DirectorSSale−500$34.09−$17.0K−5.3%9.01K after
Oct 5, 2021 (view filing)Oct 14 daysFlier Jeffrey S.DirectorSSale−6.00K$30.89−$185.3K−21.2%22.3K after
Nov 15, 2021 (view filing)Nov 11-154 daysMyles Edward HChief Financial OfficerSSale−78.3K$35.14−$2.75M−76.4%24.1K after3 lots
Jun 24, 2022 (view filing)Jun 222 daysNashat AmirDirectorPPurchase+1.20M$4.90+$5.87MNew position206.9K after2 lots
Jun 24, 2022 (view filing)Jun 222 daysNashat AmirDirectorPPurchase+299.5K$4.90+$1.47M–16.5K afterDerivative2 lots
Oct 7, 2022 (view filing)4:30 PM ETOct 3-44 daysLateArtal Group S.A. and 7 others10% OwnerPPurchase+100.0K$7.60+$759.5K+1.1%8.85M after2 lots
Oct 27, 2022 (view filing)4:36 PM ETOct 252 daysArtal Group S.A. and 7 others10% OwnerPPurchase+130.3K$8.04+$1.05M+1.5%8.98M after
Jan 9, 2023 (view filing)5:22 PM ETJan 54 daysArtal Group S.A. and 7 others10% OwnerPPurchase+48.8K$9.33+$455.1K+0.5%9.03M after
Jan 11, 2023 (view filing)8:30 PM ETJan 92 daysArtal Group S.A. and 7 others10% OwnerSSale−1.09K$9.48−$10.4K0.0%9.03M after
May 2, 2023 (view filing)9:00 PM ETApr 284 daysArtal Group S.A. and 7 others10% OwnerPPurchase+31.6K$6.43+$202.8K+0.3%9.06M after
Aug 18, 2023 (view filing)Aug 162 daysParlavecchio CarynCHROSSale−1.35K$6.83−$9.24K−1.1%117.2K after
Sep 20, 2023 (view filing)Sep 182 daysQatanani MoSVP AND HEAD OF RESEARCHSSale−1.95K$6.34−$12.3K−2.0%97.0K after
Oct 16, 2023 (view filing)5:46 PM ETOct 124 daysArtal Group S.A. and 7 others10% OwnerPPurchase+2.20M$6.86+$15.1M+24.3%11.3M after2 lots
Oct 18, 2023 (view filing)Oct 162 daysAkkaraju SrinivasDirector, 10% OwnerPPurchase+2.19M$6.85+$15.0M+47.6%6.79M after
Oct 18, 2023 (view filing)5:44 PM ETOct 162 daysSamsara BioCapital, L.P. and 1 other10% OwnerPPurchase+2.19M$6.85+$15.0M+47.6%6.79M afterDuplicate filing
Nov 3, 2023 (view filing)Nov 21 dayMyles Edward HCOO & CFOSSale−35.0K$12.51−$437.9K−17.2%168.8K after10b5-1
Dec 8, 2023 (view filing)Dec 71 dayMyles Edward HCOO & CFOSSale−24.9K$17.53−$436.7K−12.9%168.8K after10b5-1
Dec 15, 2023 (view filing)Dec 141 dayQatanani MoSVP AND HEAD OF RESEARCHSSale−24.7K$18.18−$448.4K−23.4%80.8K after
Dec 29, 2023 (view filing)Dec 29Same dayMyles Edward HCOO & CFOSSale−12.5K$18.84−$234.7K−6.9%168.8K after2 lots10b5-1
Jan 18, 2024 (view filing)Jan 162 daysHo JunlinGENERAL COUNSELSSale−4.19K$15.93−$66.7K−2.6%154.4K after
Jan 18, 2024 (view filing)Jan 162 daysMyles Edward HCOO & CFOSSale−6.63K$15.93−$105.7K−3.9%162.2K after
Jan 18, 2024 (view filing)Jan 162 daysParlavecchio CarynCHROSSale−2.85K$15.93−$45.4K−2.4%114.3K after
Jan 18, 2024 (view filing)Jan 162 daysQatanani MoSVP AND HEAD OF RESEARCHSSale−2.00K$15.93−$31.9K−2.5%78.8K after
Feb 20, 2024 (view filing)Feb 164 daysBackstrom Jay T.CHIEF EXECUTIVE OFFICERSSale−11.6K$15.74−$182.8K−3.2%352.7K after
Feb 20, 2024 (view filing)Feb 164 daysHo JunlinGENERAL COUNSELSSale−3.49K$15.74−$54.9K−1.6%208.8K after
Feb 20, 2024 (view filing)Feb 164 daysParlavecchio CarynCHROSSale−3.75K$15.74−$59.0K−2.3%157.7K after
Feb 20, 2024 (view filing)Feb 164 daysQatanani MoCHIEF SCIENTIFIC OFFICERSSale−2.51K$15.74−$39.5K−1.7%147.0K after
Feb 21, 2024 (view filing)Feb 165 daysMyles Edward HCOO & CFOSSale−4.74K$15.74−$74.7K−2.2%211.0K after
Jun 18, 2024 (view filing)Jun 171 dayHo JunlinGENERAL COUNSELSSale−4.70K$8.98−$42.2K−2.2%204.1K after
Jun 18, 2024 (view filing)Jun 171 dayMyles Edward HCOO & CFOSSale−9.46K$8.98−$84.9K−4.5%201.5K after
Jun 18, 2024 (view filing)Jun 171 dayParlavecchio CarynCHROSSale−4.30K$8.98−$38.7K−2.7%153.4K after
Jun 18, 2024 (view filing)Jun 171 dayQatanani MoCHIEF SCIENTIFIC OFFICERSSale−2.31K$8.99−$20.8K−1.6%144.7K after
Aug 19, 2024 (view filing)Aug 163 daysParlavecchio CarynCHROSSale−1.45K$9.33−$13.5K−0.9%152.0K after
Sep 19, 2024 (view filing)Sep 163 daysLateQatanani MoCHIEF SCIENTIFIC OFFICERSSale−1.94K$8.58−$16.6K−1.3%142.8K after
Oct 7, 2024 (view filing)Oct 7Same dayMarantz Jing L.CHIEF MEDICAL OFFICERSSale−109.4K$27.21−$2.98M−60.0%72.9K after3 lots10b5-1
Oct 7, 2024 (view filing)Oct 7Same daySacco TraceyCHIEF COMMERCIAL OFFICERSSale−30.0K$25.62−$768.7K−37.8%49.3K after2 lots10b5-1
Oct 7, 2024 (view filing)Oct 7Same dayMyles Edward HCOO & CFOSSale−206.2K$26.56−$5.48M−56.1%161.1K after4 lots10b5-1
Oct 7, 2024 (view filing)Oct 7Same dayAkkaraju SrinivasDirectorSSale−1.18M$29.25−$34.4M−17.3%5.61M after3 lots10b5-1
Oct 10, 2024 (view filing)Oct 82 daysMyles Edward HCOO & CFOSSale−37.2K$34.90−$1.30M−18.8%161.1K after10b5-1
Nov 13, 2024 (view filing)Nov 112 daysMarantz Jing L.CHIEF MEDICAL OFFICERSSale−2.10K$30.00−$63.1K−2.8%72.9K after10b5-1
Nov 26, 2024 (view filing)Nov 22-254 daysMarantz Jing L.CHIEF MEDICAL OFFICERSSale−8.52K$37.06−$315.8K−10.5%72.9K after5 lots10b5-1
Nov 27, 2024 (view filing)4:31 PM ETNov 252 daysDebbane Raymond and 4 others10% OwnerSSale−409.4K$38.49−$15.8M−3.6%10.9M after5 lots
Dec 12, 2024 (view filing)4:39 PM ETDec 102 daysDebbane Raymond and 4 others10% OwnerSSale−1.60M$41.65−$66.6M−14.7%9.25M after
Jan 21, 2025 (view filing)Jan 165 daysHo JunlinGENERAL COUNSELSSale−9.04K$44.20−$399.5K−4.4%195.0K after
Jan 21, 2025 (view filing)Jan 165 daysMyles Edward HCOO & CFOSSale−12.5K$44.20−$554.2K−7.8%148.5K after
Jan 21, 2025 (view filing)Jan 165 daysParlavecchio CarynCHROSSale−6.43K$44.20−$284.4K−4.2%145.6K after
Jan 21, 2025 (view filing)Jan 165 daysQatanani MoCHIEF SCIENTIFIC OFFICERSSale−7.35K$44.20−$324.7K−5.1%135.4K after
Jan 21, 2025 (view filing)Jan 165 daysSacco TraceyChief Commercial OfficerSSale−3.89K$44.20−$171.9K−7.9%45.4K after
Jan 21, 2025 (view filing)Jan 165 daysMarantz Jing L.CHIEF MEDICAL OFFICERSSale−5.66K$44.20−$250.0K−7.8%67.2K after